2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
pmid:
Trickler WJ et al. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. 2010 AAPS PharmSciTech pmid:20238190
Souza C et al. Effect of Liquid Crystalline Systems Containing Antimicrobial Compounds on Infectious Skin Bacteria. 2017 AAPS PharmSciTech pmid:28028794
Trickler WJ et al. A novel nanoparticle formulation for sustained paclitaxel delivery. 2008 AAPS PharmSciTech pmid:18431660
Panapisal V et al. Formulation of microemulsion systems for dermal delivery of silymarin. 2012 AAPS PharmSciTech pmid:22350738
Lian R et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. 2011 AAPS PharmSciTech pmid:21948306
Madheswaran T et al. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. 2014 AAPS PharmSciTech pmid:24222268
Jain S et al. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement. 2018 AAPS PharmSciTech pmid:29532426
Rachmawati H et al. Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study. 2015 AAPS PharmSciTech pmid:25511810
Estracanholli EA et al. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies. 2014 AAPS PharmSciTech pmid:24980082
Trivino A et al. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles. 2019 AAPS PharmSciTech pmid:30617602
Li Q et al. Cubic Liquid Crystalline Gels Based on Glycerol Monooleate for Intra-articular Injection. 2018 AAPS PharmSciTech pmid:29027137
Jain S et al. Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles. 2018 AAPS PharmSciTech pmid:28785860
Lai J et al. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. 2009 AAPS PharmSciTech pmid:19636709
Schmiedl UP et al. Magnetic resonance imaging of the hepatobiliary system: intestinal absorption studies of manganese mesoporphyrin. 1995 Acad Radiol pmid:9419672
Dong YD et al. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. 2011 ACS Appl Mater Interfaces pmid:21506614
Oliveira AC et al. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing. 2014 ACS Appl Mater Interfaces pmid:24712543
Szlezak M et al. Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release. 2017 ACS Appl Mater Interfaces pmid:28029248
Kundu P et al. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy. 2012 Acta Biomater pmid:22484149
Carneiro C et al. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. 2016 Acta Biomater pmid:27150234